发明名称 PROTEOGLYCAN DEGRADING MUTANT FOR TREATMENT OF CNS
摘要 <P>PROBLEM TO BE SOLVED: To provide a mutant of the chondroitinase gene, a polypeptide derived therefrom and a method for promoting neurological functional recovery after central nervous system injury or disease. <P>SOLUTION: There are disclosed: a chondroitinase mutant gene comprising deletion, substitution or combination thereof in the structural unit, preferably being a deletion mutant of a ripening gene; a mutant chondroitinase encoded by the gene; and the preparation of the mutant. The use of the mutant in a method for promoting the diffusion of therapeutic ingredients into tissues is disclosed. The use of the mutant for neurological functional recovery after central nervous system injury or disease is also disclosed. <P>COPYRIGHT: (C)2010,JPO&INPIT
申请公布号 JP2010187685(A) 申请公布日期 2010.09.02
申请号 JP20100075727 申请日期 2010.03.29
申请人 ACORDA THERAPEUTICS INC 发明人 GRUSKIN ELLIOTT A;CAGGIANO ANTHONY O;ROY GARGI;D'SOUZA ROHINI
分类号 C12N9/88;A61K;A61K31/00;A61K38/46;A61P25/00;A61P25/02;A61P43/00;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N15/09 主分类号 C12N9/88
代理机构 代理人
主权项
地址